Embolism

• EMA approval · 2026-08-25
  EMA Authorised: Svariya (previously Rivaroxaban Koanaa) (rivaroxaban) — Koanaa Healthcare GmbH

  EMA authorised Svariya (rivaroxaban) for prevention and treatment uses related to thromboembolic conditions; managed by Koanaa Healthcare Gm…

• CLINICAL_TRIALS withdrawal · 2026-03-05
  Clinical Trial Update: Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ Catheter

  A single-center post-market study evaluating thrombolytic therapy using the Versus Catheter has been withdrawn.

• CLINICAL_TRIALS trial_result · 2023-05-19
  Clinical Trial Update: Protect the Head to Head Study [Phase 2]

  A Phase 2 clinical trial update for a study addressing embolism, status currently unknown.

• CLINICAL_TRIALS trial_result · 2020-08-19
  Clinical Trial Update: Effectiveness of NextDose for Warfarin Dose Individualization [Phase 4]

  Phase 4 trial update assessing the effectiveness of NextDose for individualizing warfarin dosing.

• CLINICAL_TRIALS trial_result · 2020-05-07
  Clinical Trial Update: Effect of a Novel Reamer-Irrigator-Aspirator on the Incidence of Fat Embolism [NA]

  Completed clinical trial evaluating a novel reamer-irrigator-aspirator for reducing fat embolism in femoral fracture patients; results poste…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2017-01-23
  Clinical Trial Update: Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients

  This completed local non-interventional study sponsored by Bayer evaluated how anticoagulation therapy is prescribed for secondary stroke pr…

• CLINICAL_TRIALS research · 2016-01-22
  Clinical Trial Update: Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy [Phase 4]

  Phase 4 clinical trial update examining bedside CYP2C19 genetic testing to guide antiplatelet therapy in patients undergoing percutaneous co…

• CLINICAL_TRIALS trial_result · 2015-03-25
  Clinical Trial Update: Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation [Phase 3]

  Phase 3 trial comparing edoxaban to warfarin in patients with atrial fibrillation has completed; results posted in 2015.

• CLINICAL_TRIALS research · 2013-06-17
  Clinical Trial Update: Oral Anticoagulation and Self-management [NA]

  This clinical trial update discusses oral anticoagulation and patient self-management for atrial fibrillation with embolism; the current tri…

• CLINICAL_TRIALS research · 2009-08-18
  Clinical Trial Update: The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts [NA]

  The RETRIEVE study evaluating the FiberNet Embolic Protection System in saphenous vein grafts has completed.